• Cy5 amine (non-sulfonated): Practical Guide for Biomolecule

  2026-06-18

  Cy5 amine (non-sulfonated) addresses the need for a bright, photostable, water-insoluble fluorescence dye for covalent labeling of biomolecules in research workflows. This reagent should not be used for direct aqueous labeling or clinical diagnostics, and it requires handling in organic solvents for optimal conjugation efficiency.

• One-step TUNEL Cy3 Apoptosis Detection Kit: Applied Workflow

  2026-06-18

  The One-step TUNEL Cy3 Apoptosis Detection Kit streamlines DNA fragmentation analysis in apoptosis research, combining high-sensitivity terminal deoxynucleotidyl transferase (TdT) labeling with robust Cy3 fluorescence. Discover protocol enhancements, real-world troubleshooting, and advanced use-cases that set this APExBIO solution apart for both tissue and cell-based studies.

• FOXO3 Suppresses HCC by Dual Inhibition of Glycolysis and Gl

  2026-06-17

  This study identifies FOXO3 as a tumor suppressor in hepatocellular carcinoma, demonstrating its coordinated repression of glycolysis and glutaminolysis via direct YAP inhibition. The findings reveal a mechanistic basis for targeting metabolic reprogramming in HCC, suggesting new therapeutic strategies for metabolic intervention.

• METTL14-m6A Modification Regulates Inflammation in Ulcerativ

  2026-06-17

  Wu et al. (2024) reveal that METTL14-driven m6A modification of lncRNA DHRS4-AS1 modulates the miR-206/A3AR pathway to attenuate inflammation in ulcerative colitis. These findings clarify a methylation-dependent mechanism underlying inflammatory injury, offering new targets for epigenetic intervention in chronic IBD.

• Optimizing Assays with Dihydrotestosterone (DHT): Data and P

  2026-06-16

  This article addresses laboratory challenges in androgen receptor and EGFR pathway research, focusing on reproducibility, signaling fidelity, and protocol optimization with Dihydrotestosterone (DHT), SKU B8214. Scenario-driven Q&A blocks offer evidence-backed guidance for experimental design, data interpretation, and reliable sourcing from APExBIO.

• L. plantarum P101 Attenuates Alcoholic Fatty Liver via AMPK

  2026-06-16

  This study demonstrates that Lactiplantibacillus plantarum P101 alleviates alcohol-induced hepatic lipid accumulation in mice through activation of the AMPK signaling pathway. The findings integrate gut microbiota composition, serum metabolomics, and targeted inhibition experiments, providing mechanistic insight into probiotic intervention for alcoholic fatty liver disease.

• Calpain Inhibitor I, ALLN: Technical Guide for Apoptosis & I

  2026-06-15

  Calpain Inhibitor I, ALLN provides potent, selective inhibition of calpain and cathepsin proteases, enabling researchers to dissect proteolytic mechanisms in apoptosis and ischemia-reperfusion injury models. This compound is ideal for workflows requiring precise protease control in non-aqueous systems but is not suitable where water solubility or clinical translation is demanded.

• GLI2 Drives Tumor Immune Evasion via WNT and Prostaglandin P

  2026-06-15

  The referenced study uncovers GLI2 as a central regulator of tumor immune evasion and resistance to immunotherapy, acting through coordinated WNT ligand and prostaglandin signaling. These findings highlight GLI2 as a promising target for combination cancer immunotherapies aiming to overcome immune checkpoint blockade resistance.

• Tigecycline: Mechanistic Insight and Innovation in Translati

  2026-06-14

  This article explores Tigecycline’s mechanistic power as a glycylcycline antibiotic, its experimental and clinical validation against multidrug-resistant bacteria, and strategic guidance for translational researchers. By bridging mechanistic details with workflow design and the latest epidemiological evidence, we chart a new path for leveraging Tigecycline in advanced infection models—moving beyond conventional product guides and illuminating its role in the future of antimicrobial innovation.

• VER 155008: Dissecting HSP70 Inhibition in Cancer and Phase

  2026-06-13

  Discover how VER 155008, a potent HSP 70 inhibitor, enables advanced exploration of apoptosis and protein phase separation in cancer research. This in-depth article uniquely connects molecular chaperone inhibition to emerging assay strategies and neurodegenerative disease models.

• Berberine Hydrochloride in Gut-Bone Axis and Osteoimmune Res

  2026-06-12

  Berberine hydrochloride enables high-impact gut-bone axis and metabolic studies by combining reproducible antibacterial, metabolic, and osteoprotective activity with practical protocol flexibility. Recent advances clarify its role in modulating intestinal tuft cells and systemic immune balance, offering new avenues for postmenopausal osteoporosis and metabolic disorder research.

• Dimetridazole in Antimicrobial Research: Protocols & Innovat

  2026-06-12

  Dimetridazole (1,2-Dimethyl-5-nitroimidazole) is redefining multidrug-resistant bacterial research by enabling synergistic combination therapies and advanced quorum sensing inhibition assays. This article provides actionable workflows, troubleshooting strategies, and a translation of breakthrough findings into practical laboratory applications.

• Nitroaromatic Nannocystin Targets AKT1 to Suppress Colorecta

  2026-06-11

  This study introduces a novel nitroaromatic nannocystin with a 21-membered macrocyclic structure that exhibits potent in vivo anticancer activity against colorectal cancer by targeting AKT1. The research demonstrates both the synthetic approach and detailed mechanism, offering a new avenue for targeted therapy of colorectal malignancies.

• Nonivamide: Capsaicin Analog for Advanced Cancer Workflows

  2026-06-11

  Nonivamide, a potent capsaicin analog from APExBIO, redefines TRPV1-driven research with robust anti-proliferative and neuroimmune-modulatory actions. This article details experimental protocol enhancements, practical troubleshooting, and workflow innovations for cancer and sensory neuron models, leveraging the latest benchmarks in translational research.

• 7-AAD Cell Viability Assay Kit: Precise Necrosis & Apoptosis

  2026-06-10

  The 7-AAD Cell Viability Assay Kit enables high-specificity detection of necrotic and late apoptotic cells using the 7-amino actinomycin D assay. Its spectral properties minimize dye interference, making it ideal for multiplexed flow cytometry viability assays. This article details the kit’s mechanism, benchmarks, and integration into advanced workflows.

16373 records 1/1092 page Next 12345 下5页 Last page